Open AccessSB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans
Author(s) -
Aili L. Lazaar,
Lisa E. Sweeney,
Alexander J. Macdonald,
Neil E. Alexis,
Chao Chen,
Ruth TalSinger
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/qjvg-0g88
Subject(s) - ex vivo , inflammation , antagonist , cxc chemokine receptors , in vivo , immunology , airway , chemistry , medicine , in vitro , chemokine , biology , biochemistry , receptor , chemokine receptor , anesthesia , microbiology and biotechnology